Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-028814
Filing Date
2014-05-09
Accepted
2014-05-09 06:04:00
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v376444_10q.htm 10-Q 411331
2 EXHIBIT 10.1 v376444_ex10-1.htm EX-10.1 32977
3 EXHIBIT 10.2 v376444_ex10-2.htm EX-10.2 58905
4 EXHIBIT 31.1 v376444_ex31-1.htm EX-31.1 8064
5 EXHIBIT 31.2 v376444_ex31-2.htm EX-31.2 8125
6 EXHIBIT 32.1 v376444_ex32-1.htm EX-32.1 3485
7 EXHIBIT 32.2 v376444_ex32-2.htm EX-32.2 3374
  Complete submission text file 0001144204-14-028814.txt   7683613

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptbg-20140331_cal.xml EX-101.CAL 50070
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptbg-20140331_def.xml EX-101.DEF 429759
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptbg-20140331_lab.xml EX-101.LAB 515999
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptbg-20140331_pre.xml EX-101.PRE 493699
12 XBRL INSTANCE DOCUMENT ptbg-20140331.xml EX-101.INS 1244055
13 XBRL TAXONOMY EXTENSION SCHEMA ptbg-20140331.xsd EX-101.SCH 89793
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26505
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51474 | Film No.: 14826908
SIC: 2834 Pharmaceutical Preparations